Ticker: DYN

Company: Dyne Therapeutics, Inc.

Person: Jason P Rhodes, director

Transaction date: May 4, 2026

Reporting date: May 6, 2026

Average share price: 18.14361871386674

Sold 106723.0 shares for 1936341.42